Covered recipient · General Payments record
BARRON E ROTH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023
$181.34
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $181.34 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $62.38 | 3 |
| ABBVIE INC. | $49.39 | 3 |
| E.R. Squibb & Sons, L.L.C. | $23.57 | 1 |
| GlaxoSmithKline, LLC. | $17.13 | 1 |
| Alkermes, Inc. | $16.08 | 1 |
| Lilly USA, LLC | $12.79 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2023 | $181.34 | 10 |
Payment records · PY2023 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $12.88 | 06/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998706391 | CMS |
| AbbVie Inc. | $15.45 | 08/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998706397 | CMS |
| AbbVie Inc. | $21.06 | 10/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998706403 | CMS |
| Alkermes, Inc. | $16.08 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1023375159 | CMS |
| E.R. Squibb & Sons, L.L.C. | $23.57 | 06/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015163751 | CMS |
| GlaxoSmithKline, LLC. | $17.13 | 08/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003757443 | CMS |
| Lilly USA, LLC | $12.79 | 11/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032577157 | CMS |
| Novo Nordisk Inc | $21.60 | 06/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005893705 | CMS |
| Novo Nordisk Inc | $20.74 | 07/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005893699 | CMS |
| Novo Nordisk Inc | $20.04 | 08/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005893693 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023
- Source files
- Dataset page · Bulk file · PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.